Endothelium-Dependent Relaxing Factors

DBCAT000866Pharmacologic class

Paracrine substances produced by the VASCULAR ENDOTHELIUM with VASCULAR SMOOTH MUSCLE relaxation (VASODILATION) activities. Several factors have been identified, including NITRIC OXIDE and PROSTACYCLIN. A DrugBank category of 1 drug. 1 of them is approved.

Also known as: Endothelium Dependent Relaxing Factor · Endothelium Dependent Relaxing Factors · Endothelium Dependent Vasodilators · Endothelium Derived Relaxant Factor · Endothelium Derived Relaxing Factor
Drugs: Nitric oxide

What you can answer from here — as of August 24, 2016

1DrugEach linked to its full drug card

Listed above

6Drug targetsEvery drug–target pair in the class, with bond type

120Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Endothelium-Dependent Relaxing Factors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account